The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications

References

• Ferrucci L, Gonzalez-Freire M, Fabbri E, et al. Measuring biological aging in humans: A quest. Aging Cell. 2019 Dec 12;19(2): e13080.
   PubMed Web of Science ®Google Scholar
• Zampino M, Ferrucci L, Semba RD. Biomarkers in the path from cellular senescence to frailty. Exp Gerontol. 2020 Jan;129:110750.
   PubMed Web of Science ®Google Scholar
• Basisty N, Kale A, Jeon OH, et al., A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18(1): e3000599. 2020.
   PubMed Web of Science ®Google Scholar
• Keshishian H, Burgess MW, Specht H, et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry. Nat Protoc. 2017 Aug;12(8):1683–1701.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Aebersold R, Anderson NL, et al. Painting a moving picture: large-scale proteomics efforts and their potential for changing patient care. Clin Chem. 2011;57(10):1357–1360.
   PubMed Web of Science ®Google Scholar
• Hsu C-Y, Ballard S, Batlle D, et al. Cross-disciplinary biomarkers research: lessons learned by the CKD biomarkers consortium. Clin J Am Soc Nephrol. 2015 May 7;10(5):894–902.
   PubMed Web of Science ®Google Scholar
• Wright I, Van Eyk JE. A roadmap to successful clinical proteomics. Clin Chem. 2017 Jan;63(1):245–247.
   PubMed Web of Science ®Google Scholar
• Shi T, Song E, Nie S, et al. Advances in targeted proteomics and applications to biomedical research. Proteomics. 2016 Aug;16(15–16):2160–2182.
   PubMed Web of Science ®Google Scholar
• Collins BC, Hunter CL, Liu Y, et al. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry. Nat Commun. 2017 Aug 21;8(1):291.
   PubMed Web of Science ®Google Scholar
• Gillet LC, Navarro P, Tate S, et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012 Jun;11(6):O111 016717.
   PubMed Web of Science ®Google Scholar
• Sajic T, Liu Y, Aebersold R. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications. Proteomics Clin Appl. 2015 Apr;9(3–4):307–321.
   PubMed Web of Science ®Google Scholar
• Meyer JG, Schilling B. Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques. Expert Rev Proteomics. 2017 May 04;14(5):419–429.
   PubMed Web of Science ®Google Scholar
• Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001 Nov;11(11):S27–31.
   PubMed Web of Science ®Google Scholar
• Campisi J, Di Fagagna FD. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007 Sep;8(9):729–740.
   PubMed Web of Science ®Google Scholar
• Acosta JC, Banito A, Wuestefeld T, et al., A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 15(8): 978–990. 2013.
   PubMed Web of Science ®Google Scholar
• Di Fagagna FD. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008 Jul 8;(7):512–522. 10.1038/nrc2440
   PubMed Web of Science ®Google Scholar
• Petrova NV, Velichko AK, Razin SV, et al. Small molecule compounds that induce cellular senescence. Aging Cell. 2016 Dec;15(6):999–1017.
   PubMed Web of Science ®Google Scholar
• Wiley CD, Velarde MC, Lecot P, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 2016;23(2):303–314.
   PubMed Web of Science ®Google Scholar
• Acosta JC, O’Loghlen A, Banito A, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008 Jun 13;133(6):1006–1018.
   PubMed Web of Science ®Google Scholar
• Coppé J-P, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic ras and the p53 tumor suppressor. PLoS Biol. 2008 [2008 Dec 2];6(12):e301.
   PubMed Web of Science ®Google Scholar
• Campisi J. Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev. 2011 Feb;21(1):107–112.
   PubMed Web of Science ®Google Scholar
• Mosteiro L, Pantoja C, Alcazar N, et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science. 2016 Nov 25;354(6315). 10.1126/science.aaf4445.
   PubMed Web of Science ®Google Scholar
• Demaria M, Ohtani N, Youssef SA, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell. 2014 December 22;31(6):722–733.
   PubMed Web of Science ®Google Scholar
• Neves J, Demaria M, Campisi J, et al. Of flies, mice, and men: evolutionarily conserved tissue damage responses and aging. Dev Cell. 2015;32(1):9–18.
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Zhu Y, van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966–972.
   PubMed Web of Science ®Google Scholar
• Tominaga K. The emerging role of senescent cells in tissue homeostasis and pathophysiology. Pathobiol Aging Age Relat Dis. 2015;5:27743.
   PubMedGoogle Scholar
• Giaimo S, Di Fagagna FD. Is cellular senescence an example of antagonistic pleiotropy? Aging Cell. 2012 Jun;11(3):378–383.
   PubMed Web of Science ®Google Scholar
• Krizhanovsky V, Xue W, Zender L, et al. Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology. Cold Spring Harb Symp Quant Biol. 2008;73:513–522.
   PubMedGoogle Scholar
• Storer M, Mas A, Robert-Moreno A, et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell. 2013;155(5):1119–1130.
   PubMed Web of Science ®Google Scholar
• Muñoz-Espín D, Cañamero M, Maraver A, et al. Programmed cell senescence during mammalian embryonic development. Cell. 2013;155(5):1104–1118.
   PubMed Web of Science ®Google Scholar
• Menon R, Behnia F, Polettini J, et al. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging (Albany NY). 2016 Feb;8(2):216–230.
   PubMedGoogle Scholar
• Chinta SJ, Woods G, Demaria M, et al. Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to parkinson’s disease. Cell Rep. 2018 Jan 23;22(4):930–940.
   PubMed Web of Science ®Google Scholar
• Childs BG, Baker DJ, Wijshake T, et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016 Oct 28;354(6311):472–477.
   PubMed Web of Science ®Google Scholar
• Demaria M, O’Leary MN, Chang J, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017 02; 7(2): 165–176.
   PubMed Web of Science ®Google Scholar
• Fu Q, Qin Z, Yu J, et al. Effects of senescent lens epithelial cells on the severity of age-related cortical cataract in humans: A case-control study. Medicine (Baltimore). 2016 Jun;95(25):e3869.
   PubMed Web of Science ®Google Scholar
• Thompson PJ, Shah A, Ntranos V, et al. Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell Metab. 2019 May 7;29(5):1045–1060 e10.
   PubMed Web of Science ®Google Scholar
• Palmer AK, Xu M, Zhu Y, et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell. 2019 Jun;18(3):e12950.
   PubMed Web of Science ®Google Scholar
• Schafer MJ, White TA, Iijima K, et al. Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 2017 Feb;23(8):14532.
   Google Scholar
• Jeon OH, Kim C, Laberge R-M, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017 Jun;23(6):775–781.
   PubMed Web of Science ®Google Scholar
• Farr JN, Xu M, Weivoda MM, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017 Sep;23(9):1072–1079.
   PubMed Web of Science ®Google Scholar
• Baar MP, Perdiguero E, Munoz-Canoves P, et al. Musculoskeletal senescence: a moving target ready to be eliminated. Curr Opin Pharmacol. 2018 Jun;40:147–155.
   PubMed Web of Science ®Google Scholar
• Baar MP, Brandt RM, Putavet DA, et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell. 2017;169:132–147.
   PubMed Web of Science ®Google Scholar
• Bussian TJ, Aziz A, Meyer CF, et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018 Oct;562(7728):578–582.
   PubMed Web of Science ®Google Scholar
• Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018 Aug;24(8):1246–1256.
   PubMed Web of Science ®Google Scholar
• Kim EC, Kim JR. Senotherapeutics: emerging strategy for healthy aging and age-related disease. BMB Rep. 2019 Jan;52(1):47–55.
   PubMed Web of Science ®Google Scholar
• Short S, Fielder E, Miwa S, et al. Senolytics and senostatics as adjuvant tumour therapy. EBioMedicine. 2019 Mar;41:683–692.
   PubMed Web of Science ®Google Scholar
• Kaplon J, Zheng L, Meissl K, et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature. 2013 Jun 6;498(7452):109–112.
   PubMed Web of Science ®Google Scholar
• Passos JF, Nelson G, Wang C, et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol. 2010;6(1):347.
   PubMedGoogle Scholar
• James ENL, Bennett MH, Parkinson EK. The induction of the fibroblast extracellular senescence metabolome is a dynamic process. Sci Rep. 2018 Aug 14;8(1):12148.
   PubMedGoogle Scholar
• Takasugi M. Emerging roles of extracellular vesicles in cellular senescence and aging. Aging Cell. 2018 Apr;17(2):e12734.
   Web of Science ®Google Scholar
• James EL, Michalek RD, Pitiyage GN, et al. Senescent human fibroblasts show increased glycolysis and redox homeostasis with extracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease. J Proteome Res. 2015 Apr 3;14(4):1854–1871.
   PubMed Web of Science ®Google Scholar
• J-P C, Patil CK, Rodier F, et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS ONE. 2010 February 12;5(2):e9188.
   Web of Science ®Google Scholar
• Kuilman T, Michaloglou C, Vredeveld LCW, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008 [Jun 13];133(6):1019–1031.
   PubMed Web of Science ®Google Scholar
• Althubiti M, Lezina L, Carrera S, et al. Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis. 2014;5(11):e1528–e1528.
   PubMedGoogle Scholar
• Kim KM, Noh JH, Bodogai M, et al. Identification of senescent cell surface targetable protein DPP4. Genes Dev. 2017 Aug 1;31(15):1529–1534.
   PubMed Web of Science ®Google Scholar
• Hoare M, Ito Y, Kang T-W, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016 Sep;18(9):979–992.
   PubMed Web of Science ®Google Scholar
• Laberge R-M, Sun Y, Orjalo AV, et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2015;17(8):1049–1061.
   PubMed Web of Science ®Google Scholar
• Velarde MC, Demaria M, Melov S, et al. Pleiotropic age-dependent effects of mitochondrial dysfunction on epidermal stem cells. Proc Natl Acad Sci U S A. 2015;112(33):10407–10412.
   PubMed Web of Science ®Google Scholar
• Comi P, Chiaramonte R, Maier JAM. Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp Cell Res. 1995 Jul;219(1):304–308.
   PubMed Web of Science ®Google Scholar
• West MD, Shay JW, Wright WE, et al. Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol. 1996 Jan-Apr;31(1–2):175–193.
   PubMed Web of Science ®Google Scholar
• Mu X-C, Higgins PJ. Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts. J Cell Physiol. 1995 Dec;165(3):647–657.
   PubMed Web of Science ®Google Scholar
• West MD, Pereira-Smith OM, Smith JR. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res. 1989 Sep;184(1):138–147.
   PubMed Web of Science ®Google Scholar
• Millis AJT, Hoyle M, McCue HM, et al. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res. 1992 Aug;201(2):373–379.
   PubMed Web of Science ®Google Scholar
• Zeng G, Millis AJT. Differential regulation of collagenase and stromelysin mRNA in late passage cultures of human fibroblasts. Exp Cell Res. 1996 Jan 10;222(1):150–156.
   PubMed Web of Science ®Google Scholar
• Coppé J-P, Desprez P-Y, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annual Review of Pathology: Mechanisms of Disease. 2010;5(1):99–118.
   PubMedGoogle Scholar
• Malaquin N, Martinez A, Rodier F. Keeping the senescence secretome under control: molecular reins on the senescence-associated secretory phenotype. Exp Gerontol. 2016 September;82:39–49.
   PubMed Web of Science ®Google Scholar
• Borghesan M, Fafián-Labora J, Eleftheriadou O, et al. Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein IFITM3. Cell Rep. 2019;27(13):3956–3971.e6. Jun 25.
   PubMed Web of Science ®Google Scholar
• Wiley CD, Liu S, Limbad C, et al. SILAC analysis reveals increased secretion of hemostasis-related factors by senescent cells. Cell Rep. 2019 [Sept 24];28(13):3329–3337.e5.
   PubMed Web of Science ®Google Scholar
• Ozcan S, Alessio N, Acar MB, et al. Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses. Aging (Albany NY). 2016 Jul;8(7):1316–1329.
   PubMedGoogle Scholar
• Lefèvre C, Auclair M, Boccara F, et al. Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin. Arterioscler Thromb Vasc Biol. 2010 [Dec];30(12):2611–2620.
   PubMed Web of Science ®Google Scholar
• Hernandez-Vallejo SJ, Beaupere C, Larghero J, et al. HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin. Aging Cell. 2013 [Dec];12(6):955–965.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Biancotto A, Moaddel R, et al. Plasma proteomic signature of age in healthy humans. Aging Cell. 2018 Oct;17(5):e12799.
   PubMed Web of Science ®Google Scholar
• Bidadkosh A, Lambooy SPH, Heerspink HJ, et al. Predictive properties of biomarkers GDF-15, NTproBNP, and hs-TnT for morbidity and mortality in patients with type 2 diabetes with nephropathy. Diabetes Care. 2017 June;40(6):784–792.
   PubMed Web of Science ®Google Scholar
• Daniels LB, Clopton P, Laughlin GA, et al. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the rancho bernardo study. Circulation. 2011 [May 17];123(19):2101–2110.
   PubMed Web of Science ®Google Scholar
• Ho JE, Mahajan A, Chen M-H, et al. Clinical and genetic correlates of growth differentiation factor 15 in the community. Clin Chem. 2012 [Nov];58(11):1582–1591.
   PubMed Web of Science ®Google Scholar
• Ho JE, Hwang S-J, Wollert KC, et al. Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem. 2013 November;59(11):1613–1620.
   PubMed Web of Science ®Google Scholar
• Rohatgi A, Patel P, Das SR, et al. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the dallas heart study. Clin Chem. 2012 [Jan];58(1):172–182.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Zethelius B, Berglund L, et al. GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men. PloS One. 2013;8(12):e78797.
   PubMed Web of Science ®Google Scholar
• Wollert KC, Kempf T, Wallentin L. Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem. 2017 January 01;63(1):140–151.
   PubMed Web of Science ®Google Scholar
• Guo Y, Ayers JL, Carter KT, et al. Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15. Aging Cell. 2019 Dec;18(6):e13013.
   PubMed Web of Science ®Google Scholar
• Bhat R, Crowe EP, Bitto A, et al. Astrocyte senescence as a component of Alzheimer’s disease. PloS One. 2012;7(9):e45069.
   PubMed Web of Science ®Google Scholar
• Chen Y-K, Tung C-W, Lee J-Y, et al. Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma. Sci Rep. 2016 July 20;6(1):30057.
   PubMedGoogle Scholar
• Rosas IO, Richards TJ, Konishi K, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008 April;5(4):e93.
   PubMed Web of Science ®Google Scholar
• Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarker s and potential therapeutic targets in human cancer. J clin oncol. 2009 November 1;27(31):5287–5297.
   PubMed Web of Science ®Google Scholar
• Chang AC-M, Doherty J, Huschtscha LI, et al. STC1 expression is associated with tumor growth and metastasis in breast cancer. Clin Exp Metastasis. 2015 [Jan];32(1):15–27.
   PubMed Web of Science ®Google Scholar
• Du Y-Z, Gu X-H, Cheng S-F, et al. The oncogenetic role of stanniocalcin 1 in lung adenocarcinoma: a promising serum candidate biomarker for tracking lung adenocarcinoma progression. Tumor Biology. 2016 [Apr];37(4):5633–5644.
   PubMedGoogle Scholar
• Ohkouchi S, Ono M, Kobayashi M, et al. Myriad Functions of Stanniocalcin-1 (STC1) cover multiple therapeutic targets in the complicated pathogenesis of idiopathic pulmonary fibrosis (IPF). Clinical medicine insights. Circulatory, respiratory and pulmonary medicine. 2015;9(Suppl 1):91–96.
   PubMedGoogle Scholar
• Pan JS-C, Huang L, Belousova T, et al. Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. J Am Soc Nephrol. 2015 Feb;26(2):364–378.
   PubMed Web of Science ®Google Scholar
• Su J, Guo B, Zhang T, et al. Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients. Tumour Biol. 2015 Aug;36(8):6333–6339.
   PubMedGoogle Scholar
• Shahim P, Blennow K, Johansson P, et al. Cerebrospinal fluid stanniocalcin-1 as a biomarker for alzheimer’s disease and other neurodegenerative disorders. NeuroMolecular Medicine. 2017 Mar;19(1):154–160.
   PubMed Web of Science ®Google Scholar
• Hernandez-Segura A, de Jong TV, Melov S, et al. Unmasking transcriptional heterogeneity in senescent cells. Curr Biol. 2017 Sep 11;27(17):2652–2660.e4.
   PubMed Web of Science ®Google Scholar
• Casella G, Munk R, Kim KM, et al. Transcriptome signature of cellular senescence. Nucleic Acids Res. 2019 August 22;47(14):7294–7305.
   PubMed Web of Science ®Google Scholar
• Park H, Kim C-H, Jeong J-H, et al. GDF15 contributes to radiation-induced senescence through the ROS-mediated p16 pathway in human endothelial cells.. Oncotarget. 2016 Mar 1;7(9):9634–9644.
   PubMedGoogle Scholar
• Camussi G, Deregibus MC, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010 Nov;78(9):838–848.
   PubMed Web of Science ®Google Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3.
   Google Scholar
• van der Pol E, Boing AN, Harrison P, et al. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012 Jul;64(3):676–705.
   PubMed Web of Science ®Google Scholar
• Yanez-Mo M, Siljander PR-M, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4(1):27066.
   PubMed Web of Science ®Google Scholar
• Boukouris S, Mathivanan S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl. 2015 Apr;9(3–4):358–367.
   PubMed Web of Science ®Google Scholar
• Gámez-Valero A, Lozano-Ramos SI, Bancu I, et al. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol. 2015;6:6.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hubal MJ, Kraus VB. Immune cell extracellular vesicles and their mitochondrial content decline with ageing. Immunity & Ageing. 2020 Jan 04;17(1):1.
   PubMed Web of Science ®Google Scholar
• Jablonska J, Pietrowska M, Ludwig S, et al. Challenges in the isolation and proteomic analysis of cancer exosomes-implications for translational research. Proteomes. 2019 May 15;7(2).
   Google Scholar
• Ludwig N, Whiteside TL, Reichert TE. Challenges in exosome isolation and analysis in health and disease. Int J Mol Sci. 2019 Sep 21;20(19).
   Google Scholar
• Greening DW, Xu R, Ji H, et al. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol. 2015;1295:179–209.
   PubMedGoogle Scholar
• Yu LL, Zhu J, Liu JX, et al. A comparison of traditional and novel methods for the separation of exosomes from human samples. Biomed Res Int. 2018;2018:3634563.
   PubMed Web of Science ®Google Scholar
• Nelson G, Wordsworth J, Wang C, et al. A senescent cell bystander effect: senescence-induced senescence. Aging Cell. 2012 Apr;11(2):345–349.
   PubMed Web of Science ®Google Scholar
• Jakhar R, Crasta K. Exosomes as emerging pro-tumorigenic mediators of the senescence-associated secretory phenotype. Int J Mol Sci. 2019 May 2420: 10.
   Web of Science ®Google Scholar
• Lehmann BD, Paine MS, Brooks AM, et al. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 2008 Oct 01;68(19):7864–7871.
   PubMed Web of Science ®Google Scholar
• Jeon OH, Wilson DR, Clement CC, et al. Senescence cell-associated extracellular vesicles serve as osteoarthritis disease and therapeutic markers. JCI Insight. 2019 Apr 04;4(7). DOI:10.1172/jci.insight.125019.
   Web of Science ®Google Scholar
• Kavanagh EL, Lindsay S, Halasz M, et al. Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells. Oncogenesis. 2017 Oct 9;6(10):e388.
   PubMed Web of Science ®Google Scholar
• Effenberger T, von der Heyde J, Bartsch K, et al. Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding. Faseb J. 2014 Nov;28(11):4847–4856.
   PubMed Web of Science ®Google Scholar
• Takasugi M, Okada R, Takahashi A, et al. Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat Commun. 2017 Jun 6;8(1):15729.
   PubMedGoogle Scholar
• Stastna M, Van Eyk JE. Secreted proteins as a fundamental source for biomarker discovery. Proteomics. 2012 Feb;12(4–5):722–735.
   PubMed Web of Science ®Google Scholar
• Erickson BK, Rose CM, Braun CR, et al. A strategy to combine sample multiplexing with targeted proteomics assays for high-throughput protein signature characterization. Mol Cell. 2017 Jan 19;65(2):361–370.
   PubMed Web of Science ®Google Scholar
• Lehallier B, Gate D, Schaum N, et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat Med. 2019;25(12):1843–1850.
   PubMed Web of Science ®Google Scholar
• Zangari M, Siegel E, Barlogie B, et al. Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy. Blood. 2002;100(4):1168–1171.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Lim K-M, Noh J-Y, et al. Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis. Toxicol Sci. 2011;124(1):215–224.
   PubMed Web of Science ®Google Scholar
• Justice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019 Feb;40:554–563.
   PubMed Web of Science ®Google Scholar
• Schafer MJ, White TA, Evans G, et al. Exercise prevents diet-induced cellular senescence in adipose tissue. Diabetes. 2016 Jun;65(6):1606–1615.
   PubMed Web of Science ®Google Scholar
• Rossman MJ, Kaplon RE, Hill SD, et al. Endothelial cell senescence with aging in healthy humans: prevention by habitual exercise and relation to vascular endothelial function. Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H890–H895.
   PubMed Web of Science ®Google Scholar
• Werner C, Furster T, Widmann T, et al. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation. 2009 Dec 15;120(24):2438–2447.
   PubMed Web of Science ®Google Scholar
• Fontana L, Nehme J, Demaria M. Caloric restriction and cellular senescence. Mech Ageing Dev. 2018;176:19–23.
   PubMed Web of Science ®Google Scholar
• Brandhorst S, Choi In Y, Wei M, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab. 2015;22(1):86–99.
   PubMed Web of Science ®Google Scholar
• Forshed J. Experimental design in clinical ‘omics biomarker discovery. J Proteome Res. 2017 Nov 3;16(11):3954–3960.
   PubMed Web of Science ®Google Scholar
• Boja ES, Fehniger TE, Baker MS, et al. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers. J Proteome Res. 2014 Dec 5;13(12):5325–5332.
   PubMed Web of Science ®Google Scholar
• Fehniger TE, Boja ES, Rodriguez H, et al. Four areas of engagement requiring strengthening in modern proteomics today. J Proteome Res. 2014;13(12):5310–5318.
   PubMed Web of Science ®Google Scholar
• Carr SA, Abbatiello SE, Ackermann BL, et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics. 2014;13(3):907–917.
   PubMed Web of Science ®Google Scholar
• Rodriguez H, Ž T, Mesri M, et al., Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin Chem. 56(2): 237–243. 2010.
   PubMed Web of Science ®Google Scholar
• Regnier FE, Skates SJ, Mesri M, et al. Protein-based multiplex assays: mock presubmissions to the us food and drug administration. Clin Chem. 2010;56(2):165–171.
   PubMed Web of Science ®Google Scholar
• Covarrubias AJ, Lopez-Dominguez JA, Perrone R, et al. Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ macrophages. bioRxiv. 2019;609438.
   Google Scholar
• Bausch-Fluck D, Hofmann A, Wollscheid B. Cell surface capturing technologies for the surfaceome discovery of hepatocytes. Methods Mol Biol. 2012;909:1–16.
   PubMedGoogle Scholar
• van Oostrum M, Muller M, Klein F, et al. Classification of mouse B cell types using surfaceome proteotype maps. Nat Commun. 2019 Dec 16;10(1):5734.
   PubMedGoogle Scholar
• Bausch-Fluck D, Goldmann U, Muller S, et al. The in silico human surfaceome. Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10988–E10997.
   PubMed Web of Science ®Google Scholar
• Waas M, Snarrenberg ST, Littrell J, et al. SurfaceGenie: a web-based application for prioritizing cell-type specific marker candidates. bioRxiv. 2019;575969.
   Google Scholar
• Bausch-Fluck D, Hofmann A, Bock T, et al. A mass spectrometric-derived cell surface protein atlas. PLoS One. 2015;10(3):e0121314.
   PubMedGoogle Scholar
• Boheler KR, Gundry RL. Concise review: cell surface n-linked glycoproteins as potential stem cell markers and drug targets. Stem Cells Transl Med. 2017;6(1):131–138.
   PubMed Web of Science ®Google Scholar
• Fujinaka CM, Waas M, Gundry RL. Mass spectrometry-based identification of extracellular domains of cell surface n-glycoproteins: defining the accessible surfaceome for immunophenotyping stem cells and their derivatives. In: Boheler KR, Gundry RL, editors. The surfaceome: methods and protocols. New York: Springer New York; 2018. p. 57–78.
   Google Scholar
• Kuhlmann L, Cummins E, Samudio I, et al. Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Rev Proteomics. 2018;15(3):259–275.
   PubMed Web of Science ®Google Scholar
• Xie X, Shah S, Holtz A, et al. Simultaneous affinity enrichment of two post-translational modifications for quantification and site localization. J Vis Exp. 2020 February;27: 156.
   Google Scholar
• Basisty N, Meyer JG, Wei L, et al. Simultaneous quantification of the acetylome and succinylome by ‘one-pot’ affinity enrichment. Proteomics. 2018 Sep;18(17):e1800123.
   PubMed Web of Science ®Google Scholar
• Nakayasu ES, Burnet MC, Walukiewicz HE, et al. Ancient regulatory role of lysine acetylation in central metabolism. mBio. 2017 Nov 28;8(6). 10.1128/mBio.01894-17.
   PubMed Web of Science ®Google Scholar
• Paluvai H, Di Giorgio E, Brancolini C. The histone code of senescence. Cells. 2020 February 18;9(2).
   PubMed Web of Science ®Google Scholar